Heuristic modeling of macromolecule release from PLGA microspheres
暂无分享,去创建一个
Jakub Szlęk | Renata Jachowicz | Aleksander Mendyk | Adam Pacławski | Raymond Lau | R. Jachowicz | Raymond Lau | Adam Pacławski | J. Szlęk | A. Mendyk
[1] A. Lamprecht,et al. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] John C. Nash,et al. Unifying Optimization Algorithms to Aid Software System Users: optimx for R , 2011 .
[3] M. Alonso,et al. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[4] María J. Alonso,et al. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .
[5] C. H. Wang,et al. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation , 2003 .
[6] K. Griebenow,et al. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. , 2006, Journal of pharmaceutical sciences.
[7] Hao Ying,et al. Essentials of fuzzy modeling and control , 1995 .
[8] M. Ghanei,et al. Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases , 2012, Journal of Nanobiotechnology.
[9] O. Corrigan,et al. Quantifying drug release from PLGA nanoparticulates. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] Shufen Ma,et al. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. , 2011, International journal of pharmaceutics.
[11] Ying Wang,et al. Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats , 2011, Acta Pharmacologica Sinica.
[12] K. Zhu,et al. Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions , 2004, Journal of microencapsulation.
[13] J. Emami,et al. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats , 2010, Biopharmaceutics & drug disposition.
[14] Steven P Schwendeman,et al. Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. , 2007, Molecular pharmaceutics.
[15] M. Alonso,et al. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[17] O. Corrigan,et al. An Investigation of the Mechanism of Release of the Amphoteric Drug Amoxycillin from Poly(d,l-Lactide-co-glycolide) Matrices , 2002, Pharmaceutical development and technology.
[18] T. Park,et al. Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release. , 2001, International journal of pharmaceutics.
[19] E. Topp,et al. Physical properties of PLGA films during polymer degradation , 2009 .
[20] Juergen Siepmann,et al. A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations , 2002, Pharmaceutical Research.
[21] V. Préat,et al. PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[22] A. Göpferich,et al. Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.
[23] Anders Axelsson,et al. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. , 2011, International journal of pharmaceutics.
[24] P. Deluca,et al. Development of a dialysis in vitro release method for biodegradable microspheres , 2005, AAPS PharmSciTech.
[25] Tae Gwan Park,et al. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[26] S. De,et al. Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy , 2004, AAPS PharmSciTech.
[27] Oliver Lambert,et al. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders. , 2008, International journal of pharmaceutics.
[28] Rubiana M Mainardes,et al. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. , 2005, International journal of pharmaceutics.
[29] Hirenkumar K. Makadia,et al. Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .
[30] M. L. La Rotonda,et al. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[31] Jacek M. Zurada,et al. Perturbation method for deleting redundant inputs of perceptron networks , 1997, Neurocomputing.
[32] Xuesi Chen,et al. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. , 2009, International journal of pharmaceutics.
[33] Renata Jachowicz,et al. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology , 2007, Expert Syst. Appl..
[34] Mauro Ferrari,et al. Mesoporous Silicon‐PLGA Composite Microspheres for the Double Controlled Release of Biomolecules for Orthopedic Tissue Engineering , 2012 .
[35] Martin Crane,et al. Quantitative multi-agent models for simulating protein release from PLGA bioerodible nano- and microspheres. , 2008, Journal of pharmaceutical and biomedical analysis.
[36] Sebastian Polak,et al. Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks , 2013, Drug design, development and therapy.
[37] Tae Gwan Park,et al. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. , 2002, Biomaterials.
[38] G. Puras,et al. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] K Zygourakis,et al. Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach. , 1996, Biomaterials.
[40] H. Takeuchi,et al. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[41] Jagdish Singh,et al. Effect of additives on the release of a model protein from PLGA microspheres , 2001, AAPS PharmSciTech.
[42] P. Weston,et al. Effect of protein molecular weight on release from micron-sized PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.